Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine

by Christoph Röcken, Anu Amallraja, Christine Halske, Luka Opasic, Arne Traulsen, Hans-Michael Behrens, Sandra Krüger, Anne Liu, Jochen Haag, Jan-Hendrik Egberts, Philip Rosenstiel, Tobias Meißner
Published 2021

Tumor Heterogeneity and Consequences for Bladder Cancer Treatment

by Etienne Lavallee, John P. Sfakianos, David J. Mulholland
Published 2021

Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients

by Gedmante Radziuviene, Gedmante Radziuviene, Allan Rasmusson, Allan Rasmusson, Renaldas Augulis, Renaldas Augulis, Ruta Barbora Grineviciute, Dovile Zilenaite, Dovile Zilenaite, Aida Laurinaviciene, Aida Laurinaviciene, Valerijus Ostapenko, Arvydas Laurinavicius, Arvydas Laurinavicius
Published 2021

A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer

by Andrea Angius, Antonio Mario Scanu, Caterina Arru, Maria Rosaria Muroni, Ciriaco Carru, Alberto Porcu, Paolo Cossu-Rocca, Maria Rosaria De Miglio
Published 2021

Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities

by Sharanya Maanasi Kalasekar, Chad H. VanSant-Webb, Kimberley J. Evason
Published 2021

Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance

by Kostas Palamaris, Evangelos Felekouras, Stratigoula Sakellariou
Published 2021